AMWL:NYE-American Well Corporation (USD)

COMMON STOCK | Health Information Services | NYE

Last Closing Price

USD 8.66

Change

0.00 (0.00)%

Market Cap

USD 2.10B

Volume

3.82M

Avg Analyst Target

USD 17.50 (+102.08%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

American Well Corporation operates as a telehealth company that enables digital delivery of care for healthcare. Its application offers urgent care; pediatrics; therapy; menopause nutrition; menopause counseling; telestroke; population health management; telepsychiatry; pregnancy and postpartum care; pregnancy and postpartum therapy; breastfeed support; and menopause care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-24 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VEEV Veeva Systems Inc

N/A

USD49.18B 122.35 94.12
TDOC Teladoc Health Inc

N/A

USD21.94B N/A N/A
DOCS Doximity Inc.

N/A

USD12.02B 208.87 152.77
PHR Phreesia Inc

N/A

USD3.36B 2.91 N/A
AGTI Agiliti Inc

N/A

USD2.97B N/A 14.50
EVH Evolent Health Inc

N/A

USD2.69B N/A 185.47
CNVY Convey Holding Parent Inc.

N/A

USD0.56B N/A 19.13
CSLT Castlight Health Inc

N/A

USD0.27B N/A N/A
NXU Novus Capital Corporation II

N/A

N/A N/A N/A
2175 SMS Co Ltd

N/A

N/A N/A N/A

ETFs Containing AMWL

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -65.81% 17% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.81% 17% F 2% F
Trailing 12 Months  
Capital Gain -73.37% 17% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -73.37% 17% F 1% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 30.49% 43% F 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.49% 43% F 87% B+
Risk Return Profile  
Volatility (Standard Deviation) 422.35% 14% F 2% F
Risk Adjusted Return 7.22% 29% F 16% F
Market Capitalization 2.10B 33% F 60% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 1.76 78% C+ 54% F
Price / Cash Flow Ratio -18.70 67% D+ 91% A-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -23.07% 22% F 15% F
Return on Invested Capital -47.25% 11% F 3% F
Return on Assets -12.58% 13% F 3% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 6.30 44% F 12% F
Short Percent 7.15% 44% F 34% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector